258 related articles for article (PubMed ID: 37405477)
21. Pan-cancer analysis of cuproptosis-promoting gene signature from multiple perspectives.
Ma J; Gong B; Zhao Q
Clin Exp Med; 2023 Dec; 23(8):4997-5014. PubMed ID: 37318649
[TBL] [Abstract][Full Text] [Related]
22. Potential diagnostic biomarkers: 6 cuproptosis- and ferroptosis-related genes linking immune infiltration in acute myocardial infarction.
Miao M; Cao S; Tian Y; Liu D; Chen L; Chai Q; Wei M; Sun S; Wang L; Xin S; Liu G; Zheng M
Genes Immun; 2023 Aug; 24(4):159-170. PubMed ID: 37422588
[TBL] [Abstract][Full Text] [Related]
23. A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.
Ren L; Yang X; Wang W; Lin H; Huang G; Liu Z; Pan J; Mao X
Front Genet; 2023; 14():1096783. PubMed ID: 36911392
[No Abstract] [Full Text] [Related]
24. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
[TBL] [Abstract][Full Text] [Related]
25. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.
Zhang W; Qu H; Ma X; Li L; Wei Y; Wang Y; Zeng R; Nie Y; Zhang C; Yin K; Zhou F; Yang Z
Front Immunol; 2023; 14():1179742. PubMed ID: 37622116
[TBL] [Abstract][Full Text] [Related]
26. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Feng L; Li G; Li D; Duan G; Liu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
[TBL] [Abstract][Full Text] [Related]
27. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
Jin D; Yuan L; Li F; Wang S; Mao Y
BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
[TBL] [Abstract][Full Text] [Related]
28. A novel ferroptosis-related gene signature associated with cuproptosis for predicting overall survival in breast cancer patients.
Zhang X; Zhang Q
Acta Biochim Pol; 2023 Nov; 70(4):875-884. PubMed ID: 37930188
[TBL] [Abstract][Full Text] [Related]
29. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
30. Development and Verification of a novel cuproptosis- and immune-associated based prognostic genetic signature for pancreatic ductal adenocarcinoma.
Xu X; Liang JH; Xu QC; Yin XY
Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102089. PubMed ID: 36707046
[TBL] [Abstract][Full Text] [Related]
31. Construction of a novel pyrotosis-related prognostic model of esophageal square cell carcinoma and determination of the anti-tumor effect of WFDC12.
Zhuang Y; Wang L; Ji C; Sun Y; Shao F
Funct Integr Genomics; 2023 May; 23(2):177. PubMed ID: 37225895
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
33. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
Pan Y; Zhang Q; Zhang H; Kong F
Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
[TBL] [Abstract][Full Text] [Related]
35. A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma.
Huan C; Gao J
Math Biosci Eng; 2022 Aug; 19(12):12127-12145. PubMed ID: 36653989
[TBL] [Abstract][Full Text] [Related]
36. [Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].
Liu HR; Jiang GZ; Xin D; Yang YL; Fan QX; Meng XR; Li SL; Liu Y; Xia J; Wang F
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):666-673. PubMed ID: 34289558
[No Abstract] [Full Text] [Related]
37. Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis-related long non-coding RNA signature.
Huang Q; You Q; Zhu N; Wu Z; Xiang Z; Wu K; Ren J; Gui Y
J Clin Lab Anal; 2022 Nov; 36(11):e24723. PubMed ID: 36189780
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
[TBL] [Abstract][Full Text] [Related]
39. Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma.
Sun Q; Qin X; Zhao J; Gao T; Xu Y; Chen G; Bai G; Guo Z; Liu J
Apoptosis; 2023 Feb; 28(1-2):247-262. PubMed ID: 36344660
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.
Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H
Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]